Please Select Search Type
Please Enter Keywords
Search
Please Select Search Type
Please Enter Keywords
Search
English
Global Equine Pharmaceuticals and Supplements Market Size, Competition Landscape and Supply Chain Research Report 2025

Global Equine Pharmaceuticals and Supplements Market Size, Competition Landscape and Supply Chain Research Report 2025

Published:2025-04-10
Pages:155
Tables and Figures:170
Report ID:WENKH001053
Report Format:
Delivery:48-72h
Select Type :
Full Report
Competitive Landscape
Select Version :
Single Users License:$ 3700
Buy Now
Request Sample
Custom Reports
Contact Us
Important Clause:
Recently, our company has discovered that some websites have plagiarized, quoted and modified our original report catalog without authorization, and sold reports under our brand, which has seriously infringed our interests. Therefore, our company recommends that you contact the relevant phone number, email address or leave a message to purchase the report to prevent being deceived.
*All report contents displayed on this website are original to WENKH, and our company has the sole copyright. Any modification, reprinting or quoting in any form is prohibited without our prior written permission. Otherwise, our company reserves the right to pursue legal responsibility.
Research Scope
Table of Contents
Tables and Figures
Full Report

Research Summary

Equine pharmaceuticals and supplements refer to a category of products specifically developed for the health and well-being of horses. These include a wide range of medications, treatments, and dietary supplements designed to address various equine health concerns and nutritional needs. Equine pharmaceuticals can encompass prescription drugs used to treat illnesses, infections, or injuries in horses, while supplements are typically non-prescription products used to support overall health, performance, and specific nutritional requirements. Common equine supplements include vitamins, minerals, joint supplements, digestive aids, and herbal remedies. The use of equine pharmaceuticals and supplements is essential in maintaining the health, performance, and longevity of horses, and their application can vary widely based on the individual horse's needs, activity level, and health conditions. These products are an integral part of modern equine healthcare and management.

According to WENKH research statistics, the global Equine Pharmaceuticals and Supplements market size will reach 1,405.24 Million USD in 2025 and is projected to reach 2,017.20 Million USD by 2032, with a CAGR of 5.30% (2025-2032). Among them, the Asia-Pacific Equine Pharmaceuticals and Supplements market is undergoing rapid changes, reaching Million USD in 2025, accounting for approximately % of the global market share. It is projected to reach Million USD by 2032.

The global Equine Pharmaceuticals and Supplements market is highly competitive, with key market players including Boehringer Ingelheim, Merck Animal Health, Zoetis, Bayer Animal Health, Elanco Animal Health, Dechra Veterinary Products, CEVA, Virbac, Norbrook Equine, Kyoritsu Seiyaku, Vetoquinol, Protexin Healthcare, Audevard, Ouro Fino Saude, etc. This report categorizes the competitive landscape of the global Equine Pharmaceuticals and Supplements market into three tiers based on annual revenue, with the top three market players holding approximately  % of the total market share.

This report provides an in-depth analysis of the global Equine Pharmaceuticals and Supplements market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, revenue, sales volume and gross profit margin of major manufacturers in the global Equine Pharmaceuticals and Supplements industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different segments of Equine Pharmaceuticals and Supplements and their downstream application fields.

In terms of data coverage, this report includes extensive time-series data. Historical data spans from 2020 to 2024, providing a solid foundation for analyzing market development trends. The year 2025 is used as a base year to accurately assess the current market landscape, while forecast data extends from 2026 to 2032, using scientific analysis methods and models to offer forward-looking projections and insights into the market's future trajectory. This provides valuable reference information for industry participants and stakeholders.

The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the revenue and sales volume of Equine Pharmaceuticals and Supplements in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Equine Pharmaceuticals and Supplements market. By considering local policies, this report evaluates the market prospects of Equine Pharmaceuticals and Supplements in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.

This report places significant emphasis on data quality and reliability, leveraging a wide range of data sources to ensure accuracy and validity. Primary data collection is conducted through multiple channels, including in-depth interviews with senior corporate executives, industry experts, supply chain participants, and end consumers. This helps to gain insights into corporate strategic planning, industry policies, supply chain dynamics, and user experiences. Secondary data sources cover an extensive range, including authoritative government statistics, customs databases, industry related reports, third-party paid databases, investment research reports, academic studies, corporate financial statements, real-time media updates, and information from international organizations, all of which serve as a solid foundation for data verification and analysis.

Companies Covered

Boehringer Ingelheim

Merck Animal Health

Zoetis

Bayer Animal Health

Elanco Animal Health

Dechra Veterinary Products

CEVA

Virbac

Norbrook Equine

Kyoritsu Seiyaku

Vetoquinol

Protexin Healthcare

Audevard

Ouro Fino Saude

Product Segment

Pharmaceuticals

Supplements

Product Application

Veterinary Hospitals and Clinics

Equestrian Centers and Racetracks

Others


Chapter Scope

Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects

Chapter 2: Global Equine Pharmaceuticals and Supplements Industry Chain Analysis

Chapter 3: Global Equine Pharmaceuticals and Supplements Industry Environment Analysis and Porter's Five Forces Analysis

Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Equine Pharmaceuticals and Supplements Market (Market Share, Product Revenue and Sales Volume Comparison, Tier Division, Corporate Expansion and M&A Trends)

Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Sales Volume, Product Average Price, Product Gross Profit Margin and Geographical Sales Share)

Chapter 6: Global Equine Pharmaceuticals and Supplements Product Segment, Downstream Application and Major Regional Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 7: North America Equine Pharmaceuticals and Supplements Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 8: Europe Equine Pharmaceuticals and Supplements Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 9: China Equine Pharmaceuticals and Supplements Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 10: Asia Pacific (excluding China) Equine Pharmaceuticals and Supplements Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 11: Latin America Equine Pharmaceuticals and Supplements Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 12: Middle East and Africa Equine Pharmaceuticals and Supplements Product Segment, Downstream Application, and Major Countries Market Size Analysis (Sales Volume, Revenue and Average Price)

Chapter 13: Research Conclusion

Chapter 14: Methodology and Data Source


Purpose and Value of the Report

Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.

Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.

Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.

Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.

Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.

Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.

Table of Content

1 Equine Pharmaceuticals and Supplements Market Overview

   1.1 Product Definition Introduction

   1.2 Global Equine Pharmaceuticals and Supplements Market Size and Growth Forecast Analysis (2020-2032)

   1.3 Equine Pharmaceuticals and Supplements Market Status and Development Prospects

       1.3.1 Equine Pharmaceuticals and Supplements Market Status

       1.3.2 Equine Pharmaceuticals and Supplements Industry Development Prospects

   1.4 Equine Pharmaceuticals and Supplements Market Overview by Product Segment

       1.4.1 Global Equine Pharmaceuticals and Supplements Market Size and Growth Forecast Analysis by Product Segment: 2020 VS 2025 VS 2032

       1.4.2 Pharmaceuticals

       1.4.3 Supplements

   1.5 Equine Pharmaceuticals and Supplements Market Overview by Product Application

       1.5.1 Global Equine Pharmaceuticals and Supplements Market Size and Growth Forecast Analysis by Product Application: 2020 VS 2025 VS 2032

       1.5.2 Veterinary Hospitals and Clinics

       1.5.3 Equestrian Centers and Racetracks

       1.5.4 Others

2 Equine Pharmaceuticals and Supplements Industry Supply Chain Analysis

   2.1 Equine Pharmaceuticals and Supplements Supply Chain

   2.2 Equine Pharmaceuticals and Supplements Industry Upstream Supply Analysis

       2.2.1 Upstream Raw Materials Supply Status

       2.2.2 Key Raw Material Suppliers

   2.3 Equine Pharmaceuticals and Supplements Midstream Manufacturers

   2.4 Equine Pharmaceuticals and Supplements Downstream Customers

   2.5 Equine Pharmaceuticals and Supplements Sales Channel Analysis

3 Equine Pharmaceuticals and Supplements Market Environment Analysis

   3.1 Equine Pharmaceuticals and Supplements Industry Policy Analysis

   3.2 Equine Pharmaceuticals and Supplements Emerging Technology Trends in the Industry

   3.3 Equine Pharmaceuticals and Supplements Restraining Factors Analysis

   3.4 Equine Pharmaceuticals and Supplements Market Porter's Five Forces Analysis

       3.4.1 Competitive Rivalry

       3.4.2 Threat of New Entrants

       3.4.3 Bargaining Power of Suppliers

       3.4.4 Bargaining Power of Buyers

       3.4.5 Threat of Substitute Products or Services

4 Global Equine Pharmaceuticals and Supplements Manufacturer Competition Landscape

   4.1 Global Equine Pharmaceuticals and Supplements Market Sales Volume, Revenue by Key Manufacturers (2021-2025)

       4.1.1 Global Equine Pharmaceuticals and Supplements Market Sales Volume by Key Manufacturers (2021-2025)

       4.1.2 Global Equine Pharmaceuticals and Supplements Market Revenue by Key Manufacturers (2021-2025)

   4.2 Global Equine Pharmaceuticals and Supplements Market Position by Key Manufacturers

   4.3 China Equine Pharmaceuticals and Supplements Market Position by Key Manufacturers

   4.4 Global Key Manufacturers Headquarter and Key Area Served

   4.5 Global Equine Pharmaceuticals and Supplements Market Expansion and M&A Dynamic

5 In-depth Analysis of Key Players

   5.1 Boehringer Ingelheim

       5.1.1 Boehringer Ingelheim Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.1.2 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Features

       5.1.3 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.1.4 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.1.5 Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue by Region

   5.2 Merck Animal Health

       5.2.1 Merck Animal Health Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.2.2 Merck Animal Health Equine Pharmaceuticals and Supplements Product Features

       5.2.3 Merck Animal Health Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.2.4 Merck Animal Health Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.2.5 Merck Animal Health Equine Pharmaceuticals and Supplements Revenue by Region

   5.3 Zoetis

       5.3.1 Zoetis Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.3.2 Zoetis Equine Pharmaceuticals and Supplements Product Features

       5.3.3 Zoetis Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.3.4 Zoetis Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.3.5 Zoetis Equine Pharmaceuticals and Supplements Revenue by Region

   5.4 Bayer Animal Health

       5.4.1 Bayer Animal Health Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.4.2 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Features

       5.4.3 Bayer Animal Health Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.4.4 Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.4.5 Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue by Region

   5.5 Elanco Animal Health

       5.5.1 Elanco Animal Health Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.5.2 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Features

       5.5.3 Elanco Animal Health Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.5.4 Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.5.5 Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue by Region

   5.6 Dechra Veterinary Products

       5.6.1 Dechra Veterinary Products Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.6.2 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Features

       5.6.3 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.6.4 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.6.5 Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue by Region

   5.7 CEVA

       5.7.1 CEVA Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.7.2 CEVA Equine Pharmaceuticals and Supplements Product Features

       5.7.3 CEVA Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.7.4 CEVA Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.7.5 CEVA Equine Pharmaceuticals and Supplements Revenue by Region

   5.8 Virbac

       5.8.1 Virbac Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.8.2 Virbac Equine Pharmaceuticals and Supplements Product Features

       5.8.3 Virbac Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.8.4 Virbac Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.8.5 Virbac Equine Pharmaceuticals and Supplements Revenue by Region

   5.9 Norbrook Equine

       5.9.1 Norbrook Equine Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.9.2 Norbrook Equine Equine Pharmaceuticals and Supplements Product Features

       5.9.3 Norbrook Equine Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.9.4 Norbrook Equine Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.9.5 Norbrook Equine Equine Pharmaceuticals and Supplements Revenue by Region

   5.10 Kyoritsu Seiyaku

       5.10.1 Kyoritsu Seiyaku Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.10.2 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Features

       5.10.3 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.10.4 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.10.5 Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue by Region

   5.11 Vetoquinol

       5.11.1 Vetoquinol Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.11.2 Vetoquinol Equine Pharmaceuticals and Supplements Product Features

       5.11.3 Vetoquinol Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.11.4 Vetoquinol Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.11.5 Vetoquinol Equine Pharmaceuticals and Supplements Revenue by Region

   5.12 Protexin Healthcare

       5.12.1 Protexin Healthcare Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.12.2 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Features

       5.12.3 Protexin Healthcare Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.12.4 Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.12.5 Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue by Region

   5.13 Audevard

       5.13.1 Audevard Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.13.2 Audevard Equine Pharmaceuticals and Supplements Product Features

       5.13.3 Audevard Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.13.4 Audevard Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.13.5 Audevard Equine Pharmaceuticals and Supplements Revenue by Region

   5.14 Ouro Fino Saude

       5.14.1 Ouro Fino Saude Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

       5.14.2 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Features

       5.14.3 Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Revenue, Sales Volume, Price and Gross Margin Analysis (2021-2025)

       5.14.4 Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue by Product Segment

       5.14.5 Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue by Region

6 Global Equine Pharmaceuticals and Supplements Market Analysis by Regions, by Product Segment and Application

   6.1 Global Equine Pharmaceuticals and Supplements Market Size and Growth Forecast by Region: 2020 VS 2025 VS 2032

       6.1.1 Global Equine Pharmaceuticals and Supplements Market Revenue by Region (2020-2025)

       6.1.2 Global Equine Pharmaceuticals and Supplements Market Revenue Forecast by Region (2026-2032)

   6.2 Global Equine Pharmaceuticals and Supplements Market Sales Volume Analysis

       6.2.1 Global Equine Pharmaceuticals and Supplements Market Sales Volume by Region (2020-2025)

       6.2.2 Global Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Region (2026-2032)

   6.3 Global Equine Pharmaceuticals and Supplements Market by Product Segment (2020-2032)

       6.3.1 Global Equine Pharmaceuticals and Supplements Market Revenue and Forecast by Product Segment

       6.3.2 Global Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast by Product Segment

   6.4 Global Equine Pharmaceuticals and Supplements Market by Product Application (2020-2032)

       6.4.1 Global Equine Pharmaceuticals and Supplements Market Revenue and Forecast by Product Application

       6.4.2 Global Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast by Product Application

7 North America Equine Pharmaceuticals and Supplements Market Analysis

   7.1 North America Equine Pharmaceuticals and Supplements Market Prospects

       7.1.1 North America Equine Pharmaceuticals and Supplements Market Revenue and Growth Forecast by Countries (2020-2032)

       7.1.2 North America Equine Pharmaceuticals and Supplements Sales Volume and Growth Forecast by Countries (2020-2032)

       7.1.3 U.S.

       7.1.4 Canada

   7.2 North America Equine Pharmaceuticals and Supplements Market by Product Segment (2020-2032)

       7.2.1 North America Equine Pharmaceuticals and Supplements Market Revenue and Forecast Analysis by Product Segment

       7.2.2 North America Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast Analysis by Product Segment

   7.3 North America Equine Pharmaceuticals and Supplements Market by Product Application (2020-2032)

       7.3.1 North America Equine Pharmaceuticals and Supplements Market Revenue and Forecast Analysis by Product Application

       7.3.2 North America Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast Analysis by Product Application

8 Europe Equine Pharmaceuticals and Supplements Market Analysis

   8.1 Europe Equine Pharmaceuticals and Supplements Market Prospects

       8.1.1 Europe Equine Pharmaceuticals and Supplements Market Revenue and Growth Forecast by Countries (2020-2032)

       8.1.2 Europe Equine Pharmaceuticals and Supplements Sales Volume and Growth Forecast by Countries (2020-2032)

       8.1.3 Germany

       8.1.4 France

       8.1.5 United Kingdom

       8.1.6 Italy

       8.1.7 Spain

       8.1.8 Benelux

   8.2 Europe Equine Pharmaceuticals and Supplements Market by Product Segment (2020-2032)

       8.2.1 Europe Equine Pharmaceuticals and Supplements Market Revenue and Forecast Analysis by Product Segment

       8.2.2 Europe Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast Analysis by Product Segment

   8.3 Europe Equine Pharmaceuticals and Supplements Market by Product Application (2020-2032)

       8.3.1 Europe Equine Pharmaceuticals and Supplements Market Revenue and Forecast Analysis by Product Application

       8.3.2 Europe Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast Analysis by Product Application

9 China Equine Pharmaceuticals and Supplements Market Analysis

   9.1 China Equine Pharmaceuticals and Supplements Market Prospects

       9.1.1 China Equine Pharmaceuticals and Supplements Revenue and Growth Forecast (2020-2032)

       9.1.2 China Equine Pharmaceuticals and Supplements Market Sales Volume and Growth Forecast (2020-2032)

   9.2 China Equine Pharmaceuticals and Supplements Market by Product Segment (2020-2032)

       9.2.1 China Equine Pharmaceuticals and Supplements Market Revenue and Forecast Analysis by Product Segment

       9.2.2 China Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast Analysis by Product Segment

   9.3 China Equine Pharmaceuticals and Supplements Market by Product Application (2020-2032)

       9.3.1 China Equine Pharmaceuticals and Supplements Market Revenue and Forecast Analysis by Product Application

       9.3.2 China Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast Analysis by Product Application

10 Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Analysis

   10.1 Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Prospects

       10.1.1 Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Revenue and Growth Forecast by Countries (2020-2032)

       10.1.2 Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Sales Volume and Growth Forecast by Countries (2020-2032)

       10.1.3 Japan

       10.1.4 South Korea

       10.1.5 India

       10.1.6 Southeast Asia

       10.1.7 Australia

   10.2 Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market by Product Segment (2020-2032)

       10.2.1 Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Revenue and Forecast Analysis by Product Segment

       10.2.2 Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast Analysis by Product Segment

   10.3 Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market by Product Application (2020-2032)

       10.3.1 Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Revenue and Forecast Analysis by Product Application

       10.3.2 Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast Analysis by Product Application

11 Latin America Equine Pharmaceuticals and Supplements Market Analysis

   11.1 Latin America Equine Pharmaceuticals and Supplements Market Prospects

       11.1.1 Latin America Equine Pharmaceuticals and Supplements Revenue and Growth Forecast by Countries (2020-2032)

       11.1.2 Latin America Equine Pharmaceuticals and Supplements Sales Volume and Growth Forecast by Countries (2020-2032)

       11.1.3 Mexico

       11.1.4 Brazil

   11.2 Latin America Equine Pharmaceuticals and Supplements Market by Product Segment (2020-2032)

       11.2.1 Latin America Equine Pharmaceuticals and Supplements Market Revenue and Forecast Analysis by Product Segment

       11.2.2 Latin America Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast Analysis by Product Segment

   11.3 Latin America Equine Pharmaceuticals and Supplements Market by Product Application (2020-2032)

       11.3.1 Latin America Equine Pharmaceuticals and Supplements Market Revenue and Forecast Analysis by Product Application

       11.3.2 Latin America Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast Analysis by Product Application

12 Middle East and Africa Equine Pharmaceuticals and Supplements Market Analysis

   12.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Prospects

       12.1.1 Middle East and Africa Equine Pharmaceuticals and Supplements Revenue and Growth Forecast by Countries (2020-2032)

       12.1.2 Middle East and Africa Equine Pharmaceuticals and Supplements Sales Volume and Growth Forecast by Countries (2020-2032)

       12.1.3 Saudi Arabia

       12.1.4 South Africa

   12.2 Middle East and Africa Equine Pharmaceuticals and Supplements Market by Product Segment (2020-2032)

       12.2.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Revenue and Forecast Analysis by Product Segment

       12.2.2 Middle East and Africa Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast Analysis by Product Segment

   12.3 Middle East and Africa Equine Pharmaceuticals and Supplements Market by Product Application (2020-2032)

       12.3.1 Middle East and Africa Equine Pharmaceuticals and Supplements Market Revenue and Forecast Analysis by Product Application

       12.3.2 Middle East and Africa Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast Analysis by Product Application

13 Research Conclusion

14 Appendix

   14.1 Methodology/Research Approach

   14.2 Research Landscape

   14.3 Research Benchmark and Hypothesis

   14.4 Data Source

       14.4.1 Primary Sources

       14.4.2 Secondary Sources

   14.5 Data Cross Validation

   14.6 Disclaimer

image.png

Table 1:Global Equine Pharmaceuticals and Supplements Product Segment Market Size and Growth Forecast Analysis (2020 VS 2025 VS 2032) & (Million USD)

Table 2:Global Equine Pharmaceuticals and Supplements Market Size and Growth Forecast Analysis by Application (2020 VS 2025 VS 2032) & (Million USD)

Table 3:Key Raw Materials and Market Concentration

Table 4:Equine Pharmaceuticals and Supplements Raw Material Suppliers and Contact Information

Table 5:Equine Pharmaceuticals and Supplements Downstream Customers List

Table 6:Equine Pharmaceuticals and Supplements Distributors/Dealers List

Table 7:Global Equine Pharmaceuticals and Supplements Market Sales Volume by Key Manufacturers (2021-2025) & (K Unit)

Table 8:Global Equine Pharmaceuticals and Supplements Market Revenue by Key Manufacturers (2021-2025) & (Million USD)

Table 9:Global Equine Pharmaceuticals and Supplements Market Position by Key Manufacturers

Table 10:China Equine Pharmaceuticals and Supplements Market Position by Key Manufacturers

Table 11:Global Key Manufacturers Headquarter and Key Area Served

Table 12:Global Equine Pharmaceuticals and Supplements Market Expansion and M&A Dynamic

Table 13:Boehringer Ingelheim Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 14:Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Features

Table 15:Boehringer Ingelheim Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 16:Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 17:Boehringer Ingelheim Equine Pharmaceuticals and Supplements Revenue by Region

Table 18:Merck Animal Health Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 19:Merck Animal Health Equine Pharmaceuticals and Supplements Product Features

Table 20:Merck Animal Health Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 21:Merck Animal Health Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 22:Merck Animal Health Equine Pharmaceuticals and Supplements Revenue by Region

Table 23:Zoetis Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 24:Zoetis Equine Pharmaceuticals and Supplements Product Features

Table 25:Zoetis Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 26:Zoetis Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 27:Zoetis Equine Pharmaceuticals and Supplements Revenue by Region

Table 28:Bayer Animal Health Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 29:Bayer Animal Health Equine Pharmaceuticals and Supplements Product Features

Table 30:Bayer Animal Health Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 31:Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 32:Bayer Animal Health Equine Pharmaceuticals and Supplements Revenue by Region

Table 33:Elanco Animal Health Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 34:Elanco Animal Health Equine Pharmaceuticals and Supplements Product Features

Table 35:Elanco Animal Health Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 36:Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 37:Elanco Animal Health Equine Pharmaceuticals and Supplements Revenue by Region

Table 38:Dechra Veterinary Products Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 39:Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Features

Table 40:Dechra Veterinary Products Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 41:Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 42:Dechra Veterinary Products Equine Pharmaceuticals and Supplements Revenue by Region

Table 43:CEVA Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 44:CEVA Equine Pharmaceuticals and Supplements Product Features

Table 45:CEVA Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 46:CEVA Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 47:CEVA Equine Pharmaceuticals and Supplements Revenue by Region

Table 48:Virbac Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 49:Virbac Equine Pharmaceuticals and Supplements Product Features

Table 50:Virbac Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 51:Virbac Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 52:Virbac Equine Pharmaceuticals and Supplements Revenue by Region

Table 53:Norbrook Equine Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 54:Norbrook Equine Equine Pharmaceuticals and Supplements Product Features

Table 55:Norbrook Equine Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 56:Norbrook Equine Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 57:Norbrook Equine Equine Pharmaceuticals and Supplements Revenue by Region

Table 58:Kyoritsu Seiyaku Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 59:Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Features

Table 60:Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 61:Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 62:Kyoritsu Seiyaku Equine Pharmaceuticals and Supplements Revenue by Region

Table 63:Vetoquinol Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 64:Vetoquinol Equine Pharmaceuticals and Supplements Product Features

Table 65:Vetoquinol Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 66:Vetoquinol Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 67:Vetoquinol Equine Pharmaceuticals and Supplements Revenue by Region

Table 68:Protexin Healthcare Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 69:Protexin Healthcare Equine Pharmaceuticals and Supplements Product Features

Table 70:Protexin Healthcare Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 71:Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 72:Protexin Healthcare Equine Pharmaceuticals and Supplements Revenue by Region

Table 73:Audevard Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 74:Audevard Equine Pharmaceuticals and Supplements Product Features

Table 75:Audevard Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 76:Audevard Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 77:Audevard Equine Pharmaceuticals and Supplements Revenue by Region

Table 78:Ouro Fino Saude Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)

Table 79:Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Features

Table 80:Ouro Fino Saude Equine Pharmaceuticals and Supplements Product Revenue (Million USD), Sales Volume (K Unit), Price (USD/Unit) and Gross Margin (2021-2025)

Table 81:Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue by Product Segment

Table 82:Ouro Fino Saude Equine Pharmaceuticals and Supplements Revenue by Region

Table 83:Global Equine Pharmaceuticals and Supplements Market Size and Growth Forecast by Region (2020 VS 2025 VS 2032) & (Million USD)

Table 84:Global Equine Pharmaceuticals and Supplements Market Revenue by Region (2020-2025) & (Million USD)

Table 85:Global Equine Pharmaceuticals and Supplements Market Share by Region (2020-2025)

Table 86:Global Equine Pharmaceuticals and Supplements Market Revenue Forecast by Region (2026-2032) & (Million USD)

Table 87:Global Equine Pharmaceuticals and Supplements Market Share Forecast by Region (2026-2032)

Table 88:Global Equine Pharmaceuticals and Supplements Market Sales by Region (2020-2025) & (K Unit)

Table 89:Global Equine Pharmaceuticals and Supplements Sales Volume Market Share by Region (2020-2025)

Table 90:Global Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Region (2026-2032) & (K Unit)

Table 91:Global Equine Pharmaceuticals and Supplements Sales Volume Market Share Forecast by Region (2026-2032)

Table 92:Global Equine Pharmaceuticals and Supplements Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 93:Global Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 94:Global Equine Pharmaceuticals and Supplements Market Sales Volume by Product Segment (2020-2025) & (K Unit)

Table 95:Global Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Product Segment (2026-2032) & (K Unit)

Table 96:Global Equine Pharmaceuticals and Supplements Market Revenue by Product Application (2020-2025) & (Million USD)

Table 97:Global Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 98:Global Equine Pharmaceuticals and Supplements Market Sales Volume by Product Application (2020-2025) & (K Unit)

Table 99:Global Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Product Application (2026-2032) & (K Unit)

Table 100:North America Equine Pharmaceuticals and Supplements Market Revenue by Countries (2020-2025) & (Million USD)

Table 101:North AmericaEquine Pharmaceuticals and Supplements Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 102:North America Equine Pharmaceuticals and Supplements Market Sales Volume by Countries (2020-2025) & K Unit)

Table 103:North America Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Countries (2026-2032) & (K Unit)

Table 104:North America Equine Pharmaceuticals and Supplements Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 105:North America Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 106:North America Equine Pharmaceuticals and Supplements Market Sales Volume by Product Segment (2020-2025) & (K Unit)

Table 107:North America Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Segment (2026-2032) & (K Unit)

Table 108:North America Equine Pharmaceuticals and Supplements Market Revenue by Product Application (2020-2025) & (Million USD)

Table 109:North America Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 110:North America Equine Pharmaceuticals and Supplements Market Sales Volume by Product Application (2020-2025) & (K Unit)

Table 111:North America Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Product Application (2026-2032) & (K Unit)

Table 112:Europe Equine Pharmaceuticals and Supplements Market Revenue by Countries (2020-2025) & (Million USD)

Table 113:Europe Equine Pharmaceuticals and Supplements Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 114:Europe Equine Pharmaceuticals and Supplements Market Sales Volume by Countries (2020-2025) & (K Unit)

Table 115:Europe Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Countries (2026-2032) & (K Unit)

Table 116:Europe Equine Pharmaceuticals and Supplements Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 117:Europe Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 118:Europe Equine Pharmaceuticals and Supplements Market Sales Volume by Product Segment (2020-2025) & (K Unit)

Table 119:Europe Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Segment (2026-2032) & (K Unit)

Table 120:Europe Equine Pharmaceuticals and Supplements Market Revenue by Product Application (2020-2025) & (Million USD)

Table 121:Europe Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 122:Europe Equine Pharmaceuticals and Supplements Market Sales Volume by Product Application (2020-2025) & (K Unit)

Table 123:Europe Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Product Application (2026-2032) & (K Unit)

Table 124:China Equine Pharmaceuticals and Supplements Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 125:China Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 126:China Equine Pharmaceuticals and Supplements Market Sales Volume by Product Segment (2020-2025) & (K Unit)

Table 127:China Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Segment (2026-2032) & (K Unit)

Table 128:China Equine Pharmaceuticals and Supplements Market Revenue by Product Application (2020-2025) & (Million USD)

Table 129:China Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 130:China Equine Pharmaceuticals and Supplements Market Sales Volume by Product Application (2020-2025) & (K Unit)

Table 131:China Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Product Application (2026-2032) & (K Unit)

Table 132:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Revenue by Countries (2020-2025) & (Million USD)

Table 133:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 134:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Sales Volume by Countries (2020-2025) & (K Unit)

Table 135:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Countries (2026-2032) & (K Unit)

Table 136:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 137:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 138:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Sales Volume by Product Segment (2020-2025) & (K Unit)

Table 139:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Segment (2026-2032) & (K Unit)

Table 140:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Revenue by Product Application (2020-2025) & (Million USD)

Table 141:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 142:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Sales Volume by Product Application (2020-2025) & (K Unit)

Table 143:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Product Application (2026-2032) & (K Unit)

Table 144:Latin America Equine Pharmaceuticals and Supplements Market Revenue by Countries (2020-2025) & (Million USD)

Table 145:Latin America Equine Pharmaceuticals and Supplements Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 146:Latin America Equine Pharmaceuticals and Supplements Market Sales Volume by Countries (2020-2025) & (K Unit)

Table 147:Latin America Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Countries (2026-2032) & (K Unit)

Table 148:Latin America Equine Pharmaceuticals and Supplements Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 149:Latin America Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 150:Latin America Equine Pharmaceuticals and Supplements Market Sales Volume by Product Segment (2020-2025) & (K Unit)

Table 151:Latin America Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Segment (2026-2032) & (K Unit)

Table 152:Latin America Equine Pharmaceuticals and Supplements Market Revenue by Product Application (2020-2025) & (Million USD)

Table 153:Latin America Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 154:Latin America Equine Pharmaceuticals and Supplements Market Sales Volume by Product Application (2020-2025) & (K Unit)

Table 155:Latin America Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Product Application (2026-2032) & (K Unit)

Table 156:Middle East and Africa Equine Pharmaceuticals and Supplements Market Revenue by Countries (2020-2025) & (Million USD)

Table 157:Middle East and Africa Equine Pharmaceuticals and Supplements Market Revenue Forecast by Countries (2026-2032) & (Million USD)

Table 158:Middle East and Africa Equine Pharmaceuticals and Supplements Market Sales Volume by Countries (2020-2025) & (K Unit)

Table 159:Middle East and Africa Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Countries (2026-2032) & (K Unit)

Table 160:Middle East and Africa Equine Pharmaceuticals and Supplements Market Revenue by Product Segment (2020-2025) & (Million USD)

Table 161:Middle East and Africa Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Segment (2026-2032) & (Million USD)

Table 162:Middle East and Africa Equine Pharmaceuticals and Supplements Market Sales Volume by Product Segment (2020-2025) & (K Unit)

Table 163:Middle East and Africa Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Segment (2026-2032) & (K Unit)

Table 164:Middle East and Africa Equine Pharmaceuticals and Supplements Market Revenue by Product Application (2020-2025) & (Million USD)

Table 165:Middle East and Africa Equine Pharmaceuticals and Supplements Market Revenue Forecast by Product Application (2026-2032) & (Million USD)

Table 166:Middle East and Africa Equine Pharmaceuticals and Supplements Market Sales Volume by Product Application (2020-2025) & (K Unit)

Table 167:Middle East and Africa Equine Pharmaceuticals and Supplements Market Sales Volume Forecast by Product Application (2026-2032) & (K Unit)

Table 168:Secondary Sources


image.png

Figure 1:Equine Pharmaceuticals and Supplements Product Scope

Figure 2:Global Equine Pharmaceuticals and Supplements Market Size and Growth Forecast Analysis (2020-2032) & (Million USD)

Figure 3:Global Equine Pharmaceuticals and Supplements Sales Volume and Growth Forecast Analysis (2020-2032) & (K Unit)

Figure 4:Global Equine Pharmaceuticals and Supplements Product Segment Market Share (2025 & 2032)

Figure 5:Global Equine Pharmaceuticals and Supplements Product Application Market Share (2025 & 2032)

Figure 6:Pharmaceuticals Product Scope

Figure 7:Supplements Product Scope

Figure 8:Veterinary Hospitals and Clinics Product Scope

Figure 9:Equestrian Centers and Racetracks Product Scope

Figure 10:Others Product Scope

Figure 11:Equine Pharmaceuticals and Supplements Industrial Chain Framework

Figure 12:Global Equine Pharmaceuticals and Supplements Market by Geographic Segmentation in 2025

Figure 13:Global Equine Pharmaceuticals and Supplements Market Share by Region (2020 VS 2025)

Figure 14:Global Equine Pharmaceuticals and Supplements Sales Volume Market Share by Region (2020 VS 2025)

Figure 15:North America Equine Pharmaceuticals and Supplements Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 16:North America Equine Pharmaceuticals and Supplements Revenue Market Share by Countries (2025 VS 2032)

Figure 17:North America Equine Pharmaceuticals and Supplements Sales Volume Market Share by Countries (2025 VS 2032)

Figure 18:U.S. Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 19:U.S. Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 20:Canada Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 21:Canada Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 22:Europe Equine Pharmaceuticals and Supplements Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 23:Europe Equine Pharmaceuticals and Supplements Revenue Market Share by Countries (2025 VS 2032)

Figure 24:Europe Equine Pharmaceuticals and Supplements Sales Volume Market Share by Countries (2025 VS 2032)

Figure 25:Germany Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 26:Germany Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 27:France Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 28:France Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 29:United Kingdom Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 30:United Kingdom Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 31:Italy Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 32:Italy Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 33:Spain Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 34:Spain Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 35:Benelux Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 36:Benelux Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 37:China Equine Pharmaceuticals and Supplements Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 38:China Equine Pharmaceuticals and Supplements Market Sales Volume and Growth Forecast (K Unit)

Figure 39:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 40:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Revenue Market Share by Countries (2025 VS 2032)

Figure 41:Asia Pacific (excl. China) Equine Pharmaceuticals and Supplements Sales Volume Market Share by Countries (2025 VS 2032)

Figure 42:Japan Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 43:Japan Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 44:South Korea Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 45:South Korea Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 46:India Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 47:India Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 48:Southeast Asia Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 49:Southeast Asia Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 50:Australia Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 51:Australia Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 52:Latin America Equine Pharmaceuticals and Supplements Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 53:Latin America Equine Pharmaceuticals and Supplements Revenue Market Share by Countries (2025 VS 2032)

Figure 54:Latin America Equine Pharmaceuticals and Supplements Sales Volume Market Share by Countries (2025 VS 2032)

Figure 55:Mexico Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 56:Mexico Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 57:Brazil Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 58:Brazil Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 59:Middle East and Africa Equine Pharmaceuticals and Supplements Market Size and Growth Forecast (2024 VS 2025 VS 2032) & (Million USD)

Figure 60:Middle East and Africa Equine Pharmaceuticals and Supplements Revenue Market Share by Countries (2025 VS 2032)

Figure 61:Middle East and Africa Equine Pharmaceuticals and Supplements Sales Volume Market Share by Countries (2025 VS 2032)

Figure 62:Saudi Arabia Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 63:Saudi Arabia Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 64:South Africa Equine Pharmaceuticals and Supplements Market Revenue and Forecast (2020-2032) & (Million USD)

Figure 65:South Africa Equine Pharmaceuticals and Supplements Market Sales Volume and Forecast (2020-2032) & (K Unit)

Figure 66:Research Methodology

Figure 67:Primary Sources

Figure 68:Data Cross Validation

Global Equine Pharmaceuticals and Supplements Revenue and Market Share by Key Players

Revenue (US$ Million)20202021202220232024
Boehringer IngelheimXXXXXXXXXX
Merck Animal HealthXXXXXXXXXX
ZoetisXXXXXXXXXX
Bayer Animal HealthXXXXXXXXXX
Elanco Animal HealthXXXXXXXXXX
Dechra Veterinary ProductsXXXXXXXXXX
CEVAXXXXXXXXXX
VirbacXXXXXXXXXX
Norbrook EquineXXXXXXXXXX
Kyoritsu SeiyakuXXXXXXXXXX
VetoquinolXXXXXXXXXX
Protexin HealthcareXXXXXXXXXX
AudevardXXXXXXXXXX
Ouro Fino SaudeXXXXXXXXXX
Other CompaniesXXXXXXXXXX
TotalXXXXXXXXXX


image.png


Global Equine Pharmaceuticals and Supplements Sales Volume and Market Share by Key Players

Sales (K Unit)20202021202220232024
Boehringer IngelheimXXXXXXXXXX
Merck Animal HealthXXXXXXXXXX
ZoetisXXXXXXXXXX
Bayer Animal HealthXXXXXXXXXX
Elanco Animal HealthXXXXXXXXXX
Dechra Veterinary ProductsXXXXXXXXXX
CEVAXXXXXXXXXX
VirbacXXXXXXXXXX
Norbrook EquineXXXXXXXXXX
Kyoritsu SeiyakuXXXXXXXXXX
VetoquinolXXXXXXXXXX
Protexin HealthcareXXXXXXXXXX
AudevardXXXXXXXXXX
Ouro Fino SaudeXXXXXXXXXX
Other CompaniesXXXXXXXXXX
TotalXXXXXXXXXX


image.png


How to Order
Contact
Fill in your contact information, and the company will quickly match the specialist to get in touch with you
You can also directly call our customer service hotline or add customer service WeChat
Samples
One on one business specialist will send the complete version of the sample
If you need to customize the report, professional analysts will be arranged to communicate with you one-on-one and provide you with customized samples
Payment
Both parties sign a report purchase contract
Support Paypal, Visa, UnionPay and MasterCard Payment
Delivery
PDF report (sent online 2-3 working days after payment)
WORD version report (sent online 2-3 working days after payment)
Paper version report (sent via EMS or DHL within 3-5 working days after payment)
After-Sales
Within six months of purchasing the report, if you have any questions about the details of our report, you can contact the report analyst at any time. The analyst will continue to follow up and solve your problem until you are satisfied
No Relevant Report Found? Please Contact Us
Custom Reports
WENKH is a global leading consulting brand for industry segments. We provide segmented market research reports, custom research, white papers and feasibility reports for all industries, focusing on market status and forecasts, competition analysis, market prospects analysis and market positioning. WENKH uses professional data and deep insights to help companies make decisions and promote win-win cooperation.
Contact Us
Ocean Tower, No.145, Hong Kong Road, Wuhan City, Hube Province, China
Copyright © WENKH.com All rights reserved.